Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone vs Combined Estradiol/Dydrogesterone Pretreatment in PCOS ICSI
NCT05300841Phase 1Unknown
- Sponsor
- Sohag University
- Start
- May 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of estradiol valerate in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Sohag University. Primary endpoints: Chemical Pregnancy Rate and Clinical Pregnancy Rate. Status: unknown.
02
Drugs
estradiol valerate
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05300841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05300841.